Since tumor cell lines and PDXs express LAMP1 with different glycan composition, making certain epitopes more or less accessible, these results suggest that different epitopes are accessible on tumor cell lines and PDXs for mAbs derived from the 2 platforms. The gene discussed is LAMP1; the disease is neoplasm.